| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a452aeb7f766d55db6921d784361b891 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate |
1993-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbfa8c3691ca38d4f2d70de158d7cb55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c412fe01a3f8431d5f8a3b3ceeefac1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_466b39dd9278fb7f24db4c24e38866e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c4f582d96378f75daa971fdd19cef13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_713cd6c4bdbaf2c56f59e1be028d1128
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5415ab7f45c473eb39c8a04d2f924bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b7a5c026244b42c7db02ab47b44689e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a51520f286f69ea90075278c71b7fb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ac35afc5c0501193b577add61a80f32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32eb92d6c366424282b67cfc0e3d1199
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13e2ca79e9c810b33f4162577c679ce3 |
| publicationDate |
1994-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0591937-A1 |
| titleOfInvention |
Use of isoquinolinone derivatives for treating hyperlipoproteinemia |
| abstract |
The use of isoquinolinone derivatives as an antiarteriosclerosis agent and antihyperlipoproteinemics. The derivatives are of the formulan n wherein R₁ is hydrogen or a C₁-C₆ alkyl group and R₂ is a C₁-C₆ alkyl group or the pharmaceutically acceptable salt thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8592416-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8993594-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004058717-A1 |
| priorityDate |
1992-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |